Market Size of Cytology Brushes Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.20 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cytology Brushes Market Analysis
The cytology brushes market is expected to register a CAGR of 5.2% over the forecast period.
The 2019 Coronavirus Disease (COVID-19) has had a significant influence on the provision of healthcare globally and has altered the practice of pathology, especially cytology. According to the study published in the International Journal of Health and Clinical Research in January 2022, the overall number of cases of cytology significantly decreased throughout the Covid era, and statistically significant drops in sample numbers in the categories of thyroid and lymphoma were seen. As a result of the aforementioned characteristics, COVID-19 significantly impacted the cytology brushes market. Additionally, the market is growing again as all of the activities return to normal and are expected to follow the same trend over the forecast period.
The growing prevalence of chronic diseases, such as respiratory diseases, urological disorders, and cancer, and increasing emphasis on early detection, are some of the factors expected to drive the overall market growth. According to the World Health Organization Updates in February 2022, cervical cancer is the fourth most common cancer in women worldwide, with 604 000 new cases and 342 000 deaths by 2020. Thus, the growing prevalence of cervical cancer is expected to drive the demand for cytology brushes for the examination of cervical cancer cells.
Additionally, the growing prevalence of respiratory diseases is likely to support the growth of the market over the forecast period. The data updated by the Centres for Disease Control and Prevention (CDC) in September 2022 mentioned that 873,000 emergency department visits with COPD were reported in 2020 in the United States, and 5% of adults were diagnosed with COPD, emphysema, or chronic bronchitis for the first time. Lung abnormalities are diagnosed using respiratory tract cytology. It also participates in a variety of infectious and inflammatory processes, which is anticipated to fuel demand for cytology brushes and accelerate the market's expansion over the forecast period.
Thus, all the above-mentioned factors are expected to boost market growth over the forecast period. However, the low sensitivity of cytology tests may restrain the market growth over the forecast period.
